Bicoll’s total synthesis of Aureothin-derivatives helped Prof. Brack-Werner from the Institute of Virology at Helmholtz Zentrum München to identify a lead compound that combines strong anti-HIV activity, photostability and improved cell safety. Planegg / Martinsried (Germany), February 5, 2020 – …
Tsukuba, Ibaraki – Bicoll presents at Ibaraki Business conference, February 19-20, 2019 On February 19 (Tue.) and 20 (Wed.), 2019, the Ministry of Economy, Trade and Industry (METI), the Japan External Trade Organization (JETRO) and Ibaraki Prefecture will jointly hold …
医薬、医療から研究機器、設備、エネルギーまで！バイオ産業の「今」が集結！ On the 9th of October Bicoll participates in 欧州のライフサイエンス企業との商談会 in Osaka 2018 European Biotech and Pharma Partnering Conference, Osaka 2018 From 10th till 12th of October Bicoll will exhibit under the umbrella of GermanPavilion (Partnering meetings are also available) @ …
The biopharmaceutical company is now one of the 62 start-up companies in the Innovation Center for Biotechnology in Martinsried near Munich. Planegg / Martinsried (Germany) – June 9, 2016 – Today, Bicoll Group announced that it has been selected by …
IZB has organized the 1st networking event for biotech companies. Thank you for the publicity supported by a number of well-known newspapers and reviewers. It was a pleasure be part of Biotech Press Lounge, Martinsried. Great talks, discussions and new …